Ceva Inc SEC Filings

Ceva, Inc. is conducting a primary offering of 3,000,000 shares of common stock at $19.50 per share, raising $58.5 million in gross proceeds. After underwriting discounts and estimated expenses, Ceva expects net proceeds of approximately $54.9 million, or about $63.2 million if underwriters exercise their 450,000‑share option in full. Shares outstanding would rise from 24,016,853 as of September 30, 2025 to 27,016,853, or 27,466,853 with the option fully exercised.

Ceva plans to use the cash mainly to increase financial flexibility, fund potential acquisitions or investments that complement its Physical AI and edge AI IP business, and support working capital, capital expenditures, share repurchases and other general corporate purposes. The company, which reported 2024 revenue of $106.9 million and a net loss of $8.8 million, highlights that investors in this deal will experience immediate dilution, as the $19.50 offering price exceeds the September 30, 2025 net tangible book value of $8.71 per share.

Ceva, Inc. is conducting a primary offering of 3,000,000 shares of common stock, with an option for underwriters to buy up to an additional 450,000 shares. The shares are expected to price around $24.57, the recent Nasdaq trading price for CEVA, generating estimated net proceeds of about $69.3 million, or $79.8 million if the option is fully exercised.

After the offering, Ceva expects to have 27,016,853 shares outstanding, based on 24,016,853 shares outstanding as of September 30, 2025. The company plans to use the cash mainly to strengthen its balance sheet and fund potential acquisitions or investments in technologies or businesses that complement its Physical AI and edge AI IP platform, and may also allocate funds to working capital, capital spending, share repurchases and other general corporate purposes.

Ceva highlights that buying in this deal will cause immediate dilution, estimating net tangible book value will rise from $8.71 to $10.31 per share, versus an assumed offering price of $24.57 per share, implying dilution of about $14.26 per share for new investors.

Ceva, Inc. (CEVA) reported third‑quarter 2025 results showing modest growth with continued losses. Revenue for the quarter was $28.4 million, up from $27.2 million a year ago, led by licensing and related revenue of $16.0 million and royalties of $12.4 million. The company posted a net loss of $2.5 million versus a $1.3 million loss a year earlier as operating expenses rose.

For the nine months, revenue reached $78.3 million (from $77.7 million), with licensing at $46.1 million and royalties at $32.2 million. Net loss widened to $9.5 million from $7.1 million. Cash from operations was an outflow of $12.1 million. Liquidity remained solid with $17.3 million in cash and cash equivalents and $132.0 million in marketable securities as of September 30, 2025.

Asia Pacific was the largest region at $57.3 million year‑to‑date, including $44.6 million from China. Trade receivables rose to $49.7 million, including higher unbilled balances tied to contracts. The company repurchased $7.2 million of shares year‑to‑date and recorded $14.1 million of equity‑based compensation. Ceva signed a new Israel office lease adding approximately $9.9 million of future commitments; as of quarter‑end, the lease had not commenced.

CEVA, Inc. reported its financial results for the quarter ended September 30, 2025, and furnished materials via an 8‑K. The company attached an earnings press release (Exhibit 99.1) and the conference call script (Exhibit 99.2).

The materials include non‑GAAP metrics for the third quarter, such as gross margin, operating income, net income, and diluted EPS. Adjustments for 2025 exclude equity‑based compensation, amortization of acquired intangibles, and costs associated with an asset acquisition. For 2024, adjustments also exclude costs associated with business acquisitions and income from remeasurement of marketable equity securities. The exhibits are furnished, not filed, and are not incorporated by reference unless expressly stated.

Ceva, Inc. reported six-month revenue of $49.9 million, roughly flat vs. $50.5 million a year earlier, with licensing up to $30.1 million and royalties down to $19.9 million. The company recorded a six-month net loss of $7.0 million (basic and diluted loss per share $0.30), and an operating loss of $8.9 million, wider than the prior-year period.

Liquidity strengthened: cash and cash equivalents rose to $29.1 million from $18.5 million, aided by maturities and a $3.47 million escrow release from the prior sale of Intrinsix. The balance sheet shows $125.6 million in marketable securities and total assets of $302.8 million. Management disclosed a lowered revenue guidance for 2025 and noted continued licensing momentum including multiple NeuPro NPU deals and record Wi‑Fi 6 chip shipments.

Ceva, Inc. announced financial results for the quarter ended June 30, 2025 and attached its earnings release and the conference call script as exhibits to this Form 8-K. The filing states that the press release and call script present the company’s GAAP results for the quarter and year ended June 30, 2025 and 2024 and also include non-GAAP measures.

The non-GAAP disclosures cover gross margin, operating income, net income and diluted income per share. The company explains that its non-GAAP amounts exclude equity-based compensation and amortization of acquired intangibles; operating income also excludes costs associated with an asset acquisition; net income measures further exclude loss from remeasurement of marketable equity securities. The filing states reconciliations are provided in the attached materials and are intended to be considered alongside GAAP results.

Morgan Stanley has filed a Schedule 13G reporting a 6.7 % beneficial ownership in CEVA Inc. (NASDAQ: CEVA) as of 30 June 2025. The firm holds 1,609,575 common shares (CUSIP 157210105). Voting and dispositive authority are entirely shared—0 shares are held with sole power, while 1,607,146 shares carry shared voting rights and 1,609,575 have shared dispositive rights. The filing is made under Rule 13d-1(b), classifying Morgan Stanley as a parent holding company/control person and indicating the stake is passive and acquired in the ordinary course of business.

Issuer headquarters: 15245 Shady Grove Rd., Rockville, MD. Reporting person headquarters: 1585 Broadway, New York, NY. Certification confirms no intent to influence control, nominate directors, or pursue activist activity. The disclosure primarily enhances transparency into CEVA’s shareholder base rather than signaling operational or strategic changes.